Email updates

Keep up to date with the latest news and content from BMC Microbiology and BioMed Central.

Open Access Highly Accessed Research article

The biochemical differentiation of Enterobacter sakazakii genotypes

Carol Iversen14, Mike Waddington2, Jim J Farmer3 and Stephen J Forsythe1*

Author Affiliations

1 School of Biomedical and Natural Sciences, Nottingham Trent University, Clifton Lane, Nottingham, NG11 8NS, UK

2 Accugenix, 223 Lake Drive, Newark, DE 19702, USA

3 Silver Hill Associates, 1781 Silver Hill Rd, Stone Mountain, GA 30087, USA

4 Quality and Safety Assurance Department, Nestlé Research Center, PO Box 44, CH 1000 Lausanne 26, Switzerland

For all author emails, please log on.

BMC Microbiology 2006, 6:94  doi:10.1186/1471-2180-6-94

The electronic version of this article is the complete one and can be found online at:

Received:7 July 2006
Accepted:26 October 2006
Published:26 October 2006

© 2006 Iversen et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



Enterobacter sakazakii is an emergent pathogen that has been associated with neonatal infections through contaminated powdered infant milk formula. The species was defined by Farmer et al. (1980) who described 15 biogroups according to the biochemical characterization of 57 strains. This present study compares genotypes (DNA cluster groups based on partial 16S rDNA sequence analysis) with the biochemical traits for 189 E. sakazakii strains.


Analysis of partial 16S rDNA sequences gave 4 well defined phylogenetic groups. Cluster group 1 was composed of the majority of strains (170/189) and included Biogroups 1–5, 7–9, 11, 13 and 14. Cluster 3 corresponded with Biogroup 15 and cluster 4 with Biogroups 6, 10 and 12. Cluster group 2 comprised a new Biogroup 16. For the isolates in this study, the four DNA cluster groups can be distinguished using the inositol, dulcitol and indole tests.


This study demonstrates an agreement between genotyping (partial 16S rDNA) and biotyping and describes a new biogroup of E. sakazakii.


Enterobacter sakazakii is an emergent pathogen that is associated with neonatal infection [1,2]. Most reported outbreaks have occurred in neonatal intensive care units and some have been linked to the ingestion of contaminated powdered infant milk formula [3,4].

E. sakazakii was defined as a new species by Farmer et al. 1980. Using DNA-DNA hybridization the previously 'yellow pigmented Enterobacter cloacae' was shown to be 41–54% related to Enterobacter and Citrobacter species. Farmer et al. [5] described 15 biogroups of E. sakazakii based on biochemical profiles with the wild type Biogroup 1 being the most common. Since 1980 prokaryotic systematics has changed with the increasing use of 16S rDNA sequence analysis [6,7]. Harada and Ishikawa [8] used DNA sequence analysis of the groEL operon to determine the phylogenetic relationship among Enterobacter, Pantoea, Klebsiella, Serratia and Erwinia species. Hoffmann and Roggenkamp [9] used hsp60 (groEL homologue) DNA sequence variation to investigate E. cloacae polyphyletic groups. Previously, it has been shown by both partial 16S rDNA and hsp60 gene sequencing that isolates identified as E. sakazakii using commercial identification kits form at least four distinct clusters [10]. Recently, an Artificial Neural Network has been published which identified key biochemical and 16S rDNA sequences that distinguish E. sakazakii from closely related organisms [11].

In this study, we compare the biogroups of 189 strains with the four 16S rDNA cluster groups. We also identified key biochemical characteristics for the differentiation of these four genotypes. This significantly extends the previous work of Farmer et al. [5], which used five strains to genetically define the species and a total of 57 strains to define biogroups.



The biochemical profiles obtained for each strain were compared to the biogroups originally described by Farmer et al [5]. Clinical strains were distributed among fourteen of the biogroups (Table 1). The defining tests were motility, Voges-Proskauer, methyl red, indole, ornithine decarboxylase, reduction of nitrate to nitrite, production of gas from D-glucose, malonate utilization and production of acid from myo-inositol and dulcitol. Where strains could not be assigned to an original biogroup, a new biogroup or subgroup was designated (Table 2). The majority of isolates (60/189) were in Biogroup 1 with the E. sakazakii ATCC 29544T type strain. These strains were motile, produced gas from glucose, produced acid from inositol, reduced nitrate and were positive for Voges-Proskauer and ornithine decarboxylase, but negative for methyl red, indole, malonate utilization and acid production from dulcitol. Biogroup 2 (n = 42) contained isolates negative for acid production from inositol; four of these were also non-motile. Biogroup 3 (non-motile) contained six strains and Biogroup 4 (ornithine negative) contained nine strains three of which were non-motile. Biogroup 5 (n = 16) was positive for malonate utilization and six of these were non-motile. Biogroup 6 (n = 2) was positive for indole and Biogroup 7 (n = 4) was negative for gas production from glucose. Biogroup 8 (n = 7) was defined by the inability to reduce nitrate. Two of these 7 strains were positive in the malonate test, three were negative for the inositol test and two were inositol negative but malonate positive. Biogroup 9 contained 13 strains that were inositol negative and malonate positive. Biogroup 10 contained one strain that was inositol negative and indole positive, while Biogroup 11 contained one strain that was inositol negative and dulcitol positive. Biogroup 12 was also represented by only one strain, which was indole and malonate positive. The seven isolates in Biogroup 13 were negative for the Voges-Proskauer reaction, three were non-motile, one was negative for methyl red and one was negative for ornithine. Biogroup 14 (n = 5) was negative for ornithine decarboxylase and inositol, with four of these strains being positive for malonate. Biogroup 15 was positive for all the tests performed except methyl red. A new group (Biogroup 16) had to be defined to accommodate 9 strains which were inositol and dulcitol positive, but indole negative. They were malonate positive, with the exception of one strain. Two strains were non-motile and one of these was also ornithine decarboxylase negative. Acid production from α-methyl-D-glucoside was included in the original study [1] and all biogroups were reported positive for this trait with the exception of Biogroup 15. As Biogroup 15 could be distinguished from the other biogroups without the α-methyl-D-glucoside test, this was not repeated for all strains in this study.

Table 1. Origins of E. sakazakii isolates used in this study.

Table 2. Assignment of strains to the biogroups originally defined by Farmer et al. [1]

Phylogenetic analysis

Partial 16S rDNA sequences (528 bp) containing less than 1% undetermined positions were obtained for all strains in this study. The sequences were analysed using the maximum parsimony method, which is an evolutionary model that searches for the simplest tree that can be constructed using the fewest inferred changes between characters. The topology was optimised using simulated annealing, a heuristic that occasionally accepts a worse tree during the course of the search allowing it to escape local optima. This method is more economical than the more usual heuristic searches (stepwise addition and hill-climbing), which can require many randon re-starts, especially with large data matrices [12]. In agreement with previous reports [10], the isolates used in this study were divided into four genomic groups by 16S rDNA sequence analysis (Fig 1). The majority (170/189) of the presumptive E. sakazakii isolates in this study clustered with the type strain (Fig. 1E. sakazakii cluster 1). Cluster 1 was composed of the majority of biogroups, Biogroups 1–5, 7–9, 11, 13 and 14. The 9 isolates forming the new proposed Biogroup 16 corresponded with E. sakazakii cluster 2 (Fig. 1 cluster 2), with between 1.23–1.89% 16S rDNA sequence difference from the E. sakazakii type strain. No strains representative of this biochemical profile were included in the original study by Farmer et al. [5].

thumbnailFigure 1. Maximum parsimony tree (unrooted) showing the four genomic clusters of E. sakazakii based on partial 16S rDNA sequence analysis. Gaps were not considered an extra state, and the topology was optimised using simulated annealing.

The six isolates in Biogroup 15 corresponded to E. sakazakii cluster 3 (Fig. 1 cluster 3). The four strains described as E. sakazakii cluster 4 (Fig. 1 cluster 4) represent Biogroups 6, 10 and 12. For this dataset, the four partial 16S rDNA cluster groups can be distinguished biochemically using the indole, dulcitol, and inositol tests (Table 4). Cluster 1 strains are variable for inositol, negative for indole, and dulcitol; with the exception of Biogroup 11, which is dulcitol positive and inositol negative. Cluster 2 – Biogroup 16 strains are positive for inositol and dulcitol but negative for indole. Cluster 3 – Biogroup 15 is positive for inositol, dulcitol and indole. Cluster 4 strains were also positive for indole but can be distinguished from Cluster 3 as they are negative for dulcitol. One of the strains in Cluster 4 was inositol negative (Biogroup 10) and one was malonate positive (Biogroup 12). There were insufficient isolates in Cluster 4 biogroups to determine whether these biogroups could be further genomically divided.

Table 3. Representative strains from each of the biogroups used in this study.

Table 4. Biochemical differentiation of E. sakazakii 16S rDNA clusters.


Farmer et al. [5] described 15 biogroups of 57 strains of E. sakazakii. Five strains were used to genetically define the species by DNA-DNA hybridization and the remaining strain definitions were phenotypic. This study defines isolates in terms of both phenotype and genotype and extends the initial 1980 [5] study with the analysis of 189 strains. According to partial 16S rDNA sequence analysis the majority of E. sakazakii strains clustered with the type strain (Figure 1), and within this cluster there was no clear further genomic division corresponding to biogroup. A second cluster of closely related strains was identified (cluster 2) which were biochemically distinct from cluster 1 and formed a biogroup that had not been previously described by Farmer et al [5]. These strains were not assigned a species match using the MicroSeq 500 or supplemental bacterial databases, but the nearest match was E. sakazakii (1.23–1.89%). Biogroup 15 [5] corresponds to E. sakazakii cluster 3, while Biogroups 6, 10 and 12 correspond to E. sakazakii cluster 4 [10,11].

Analysis of the full 16S sequence of strains corresponding to cluster groups 2 (biogroup 16) [13] and 3 (biogroup 15) [14] show these are less than 3% divergent from cluster group 1. Although DNA-DNA hybridization is the acknowledged standard for species delineation this technique was beyond the scope of this study, which focuses on evaluation of the biogroups reported when E. sakazakii was originally described. As well as defining a new biogroup (with three subgroups), this study found 10 subgroups within the original biogroups. The malonate and motility tests account for the majority of the subdivisions of the original biogroups.

In this study, the majority of food isolates belonged to Biogroups 1 and 2. All biogroups except 10 and 16 contained at least one strain from a clinical source. The greatest number of clinical strains (10 isolates) was found to belong to Biogroup 9 (Table 1). However, this included 9 isolates out of the ten from the same hospital. Therefore this may not be an indication of increased pathogenicity of this biogroup, but is likely due to an over representation of one clonal type from a single source. Most of the food isolates (including infant foods) belonged to Biogroups 1 and 2.


Biogroup 1 was the major group with approximately one third of the E. sakazakii strains (60/189). Cluster 1 was the major DNA cluster (170/189 strains), and was composed of Biogroups 1–5, 7–9, 11, 13 and 14. Cluster 3 is equivalent to Biogroup 15, and a new Biogroup 16 was designated for the strains in Cluster 2. For this dataset it is possible to differentiate the four genomic clusters using indole, dulcitol and inositol tests.


Sources of bacterial strains

A total of 189 E. sakazakii strains were analyzed in this study. Strains were from diverse food, clinical and environmental sources worldwide. The origin distribution of the isolates is given in Table 1. At least one strain from each of the biogroups described when the E. sakazakii species was designated were included and representative strains for each biogroup are given in Table 3. The type strain (NCTC 11467T) was purchased from the NCTC, London, UK, as were strains NCTC 9844, NCTC 9238 and NCTC 9846. Strain NCIMB 8272 was purchased from the NCIMB, Aberdeen, Scotland. Eleven strains, CDC 5960-70, 1895-73, 0743-75, 3523-75, 9363-75, 9369-75, 0407-77, 0996-77, 1058-77, 1716-77, and 3128-77 were donated by the CDC, Atlanta, GA, USA. Strains were also kindly donated by the following: – Nestlé Research Center, Lausanne, Switzerland; Health Products and Food branch, Health Canada; Children's Hospital Los Angeles CA, USA; Northern Foods, UK; Oxoid Ltd., Basingstoke, UK; Hospital Cèské Budéjovice, Czech Republic; Institut fûr Tierärztliche Nahrungsmittelkunde Milchwissenschaften, Justus-Liebig-Universität Gießen, Germany; Nottingham City Hospital Trust, Nottingham, UK and the Department of Medical Microbiology, Radboud, Nijmegen, Netherlands. All other strains were food and environmental isolates from the culture collection at Nottingham Trent University, Nottingham, UK.

Phenotypic characterisation

In addition to phenotypes derived from commercial biochemical test kits (Microbact GN2, Oxoid; API 20E and ID32E, BioMérieux) according to manufacturers' recommendations, the following tests were performed using conventional manual methods. Motility was determined at 37°C after 24 and 48 h using motility medium (tryptose 10 g l-1, NaCl 5 g l-1, agar 5 g l-1, pH 7.2 ± 0.2). Acid production from carbohydrates was tested in phenol red broth base (10 g l-1 peptone, 1 g l-1 yeast extract, 5 g l-1 NaCl, 0.018 g l-1 phenol red) with the addition of filter-sterilized carbohydrate solution (final concentration 0.5%). Gas production from D-glucose was determined by collection in Durham tubes. Malonate utilization was determined using sodium malonate broth (sodium malonate 3 g l-1, ammonium sulphate 2 g l-1, bromothymol blue 0.025 g l-1, NaCl 2 g l-1, yeast extract 1 g l-1, dipotassium hydrogen phosphate 0.6 g l-1, potassium dihydrogen phosphate 0.4 g l-1). The methyl red test was performed by addition of indicator (0.1 g methyl red per 300 ml 95% ethanol) to cultures grown for 48 h in 4 ml of MR-VP broth (VWR, 1.05712.0500). The Voges-Proskauer test was performed by the addition of 40% potassium hydroxide in water and 5% 1-naphthol in (95% ethanol) to cultures grown for 24 hours in MR-VP broth. Indole production was measured by the addition of Kovacs reagent (5 g p-dimethylaminobenzaldehyde, 25 ml HCl, 75 ml pentanol-1-ol) or James Reagent (70542 BioMérieux) to cultures grown for 24 h in peptone water (CM0009 Oxoid). Nitrate reduction to nitrite was determined by the addition of 1% sulphanilamide in 1 M HCl and 0.02% N-1 naphthylene diamine HCl in water to nitrate test broths. Zinc dust was added to negative tubes of nitrate-negative strains to confirm the presence of unreduced nitrate.

Genotypic characterisation

Comparative 16S rDNA sequencing (528 bp) was performed as previously described [11] by Accugenix (Newark, DE, USA) using the MicroSeq™ 500 16S rDNA Bacterial Sequencing Kit (Applied Biosystems).

A maximum parsimony tree (Fig. 1) of 16S rDNA sequences was generated using Bionumerics (Applied Maths, Belgium). Gaps were not considered an extra state and the topology was optimized using simulated annealing.

Authors' contributions

CI carried out the biochemical tests, analyzed the data and wrote the initial manuscript. MW provided the 16S rDNA sequencing, assembly and editing.

JJF and SJF edited the manuscript; SJF managed the project. All authors read and approved the final manuscript.


The authors would like to thank the Nottingham Trent University, Oxoid Ltd. (UK) and Accugenix (USA) for their support.


  1. Iversen C, Forsythe SJ: Risk profile of Enterobacter sakazakii, an emergent pathogen associated with infant milk formula.

    Trends Food Sci Technol 2003, 14:443-454. Publisher Full Text OpenURL

  2. Muytjens HL, Zanen HC, Sonderkamp HJ, Kollee LA, Wachsmuth IK, Farmer JJ: Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii.

    J Clin Microbiol 1983, 18:115-120. PubMed Abstract | PubMed Central Full Text OpenURL

  3. Simmons BP, Gelfand MS, Haas M, Metts L, Ferguson J: Enterobacter sakazakii infections in neonates associated with intrinsic contamination of a powdered infant formula.

    Inf Cont Hosp Epidemiol 1989, 10:398-401. OpenURL

  4. Himelright I, Harris E, Lorch V, Anderson M: Enterobacter sakazakii infections associated with the use of powdered infant formula – Tennessee, 2001.

    J Amer Med Assoc 2002, 287:2204-2205. Publisher Full Text OpenURL

  5. Farmer JJ III, Asbury MA, Hickman FW, Brenner DJ, and the Enterobacteriaceae Study Group: Enterobacter sakazakii: a new species of "Enterobacteriaceae" isolated from clinical specimens.

    Int J Syst Bacteriol 1980, 30:569-584. OpenURL

  6. Stackebrandt E, Goebel BM: Taxonomic note: A place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology.

    Int J System Bacteriol 1994, 44:846-849. OpenURL

  7. Stackebrandt E, Frederiksen W, Garrity GM, Grimont PAD, Kämpfer P, Maiden MCJ, Nesme X, Rosselló-Mora R, Swings J, Trüper HG, Vauterin L, Wards AC, Whitman WB: Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology.

    Int J System Evol Microbiol 2002, 52:1043-1047. Publisher Full Text OpenURL

  8. Harada H, Ishikawa H: Phylogenetical relationship based on groEL genes among phenotypically related Enterobacter, Pantoea, Klebsiella, Serratia and Erwinia species.

    J Gen Appl Microbiol 1997, 43:355-361. PubMed Abstract | Publisher Full Text OpenURL

  9. Hoffman H, Roggenkamp A: Population genetics of the nomenspecies Enterobacter cloacae.

    Appl Environ Microbiol 2003, 69:5306-5316. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  10. Iversen C, Waddington M, On SLW, Forsythe S: Identification and phylogeny of Enterobacter sakazakii relative to Enterobacter and Citrobacter.

    J Clin Microbiol 2004, 42:5368-70. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  11. Iversen C, Lancashire L, Waddington M, Forsythe S, Ball G: Identification of Enterobacter sakazakii from closely related species: The use of Artificial Neural Networks in the analysis of biochemical and 16S rDNA data.

    BMC Microbiology 2006, 6:28. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  12. Barker D: LVB: Parsimony and simulated annealing in the search for phylogenetic trees.

    Bioinformatics 2004, 20:274-275. PubMed Abstract | Publisher Full Text OpenURL

  13. Dauga C, Breeuwer P: Taxonomy and physiology of Enterobacter sakazakii. In 'Enterobacter sakazakii'. Volume Chapter 1. Edited by Farber J, Forsythe S. American Society for Microbiology; 2007.

    Manuscript awaiting approval by ASM


  14. Lehner C, Tasara T, Stephan R: 16S rRNA gene based analysis of Enterobacter sakazakii strains from different sources and development of a PCR assay for identification.

    BMC Microbiology 2004, 4:43. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL